Skip to main content
Rates starting at

$XXX USD

Select your dates at Cambria Hotel Boston, Downtown-South Boston

Save money with member-only room rates. Learn More

Your Selected Dates 1 night

  • Thursday
  • 1 night
  • Sunday
Show Member-only Room Rates
Show All Room Rates
Submit dates

Reservation: 617-752-6681

Check-in: 3:00 PM Check-out: 11:00 AM

Pets allowed: No

Book Direct Benefits
  • Members Save 7%
  • Lowest price guaranteed
  • Earn Choice Privileges points on your stay

DDR, ATR & PARP Inhibitors Summit 2022

Other
January 25, 2022 to January 27, 2022
9:00 AM - 5:00 PM
Hyatt Regency Boston, 1 Avenue de Lafayette,, Suffolk County, Massachusetts, United States, 02111

About This Event

The 5th Annual DDR, ATR & PARP Inhibitors Summit is coming at a timely inflection point within this field. With Wee1 & ATR approvals on the horizon and countless novel targets currently undergoing exciting pre-clinical validation, this unique & highly anticipated meeting unites the world experts in DDR inhibition to propel this space through the barriers it faces to clinical breakthrough. \ \ Hosted in the biopharma hub of Boston, MA, this industry-led forum once again evolves to reflect progress in the DDR therapies field with focused content on:\ \ PARP Inhibition: Next-Gen PARPi’s, PARP Resistance & the Future of PARP Inhibitors\ Developing Clinically Successful Wee1 & ATR Inhibitors for Cancer Therapy\ Developing Predictive Pre-Clinical Models in DDR to Achieve Human-Specific Translation\ Novel Methodologies & Imaging Technologies to Revolutionize Pathway Understanding, Compound Optimization & Clinical Translation\ Establishing a Pre-Clinically Validated Novel Target: Polθ\ Identifying Reliable DDR/HR Tumor Biomarkers\ Exploring the Emerging Targets in the DDR Pathway: Strategy, Execution, Development and Promise\ Managing Toxicity - Dose, Delivery, Scheduling, Patient Selection, & Stratification - Managing the Therapeutic Window & Treatment Regimes\ Next Steps in Combination Approaches - to Heighten Drug Effect & Overcome Resistance - What is the Future of the Field?